Related Experiment Videos
Cyclin-dependent kinase 5 (CDK5) and neuronal cell death
J H Weishaupt1, C Neusch, M Bähr
1Department of Neurology, University Hospital Göttingen, Robert-Koch-Str. 40, 37075, Göttingen, Germany.
Cell and Tissue Research
|April 10, 2003
Summary
Cyclin-dependent kinases (CDKs) are implicated in neuronal cell death. Deregulated CDK5, not cell cycle CDKs, appears to drive neuron loss in neurological disorders, offering therapeutic targets.
Area of Science:
- Neuroscience
- Cell Biology
- Molecular Biology
Background:
- Neurological disorders like Parkinson's, Alzheimer's, ALS, and stroke involve central nervous system (CNS) neuron loss.
- Neuronal cell death occurs via apoptosis or necrosis.
- Previous research suggested cell cycle reentry contributes to neuronal apoptosis.
Purpose of the Study:
- To review the role of cyclin-dependent kinases (CDKs) in neuronal cell death.
- To investigate the specific involvement of CDK5 in neuronal apoptosis.
- To explore potential therapeutic strategies targeting CDK5.
Main Methods:
- Literature review of existing studies on CDKs and neuronal cell death.
- Analysis of evidence supporting the cell cycle theory of neuronal apoptosis.
- Examination of data implicating CDK5 in promoting neuronal death.
Main Results:
- While CDK inhibitors show neuroprotection, evidence points to deregulated CDK5, not cell cycle CDKs, as a promoter of neuronal death.
- CDK5 is implicated as a key upstream regulator in neuronal cell death cascades.
- Identification of potential up- and downstream partners of CDK5.
Conclusions:
- Deregulated CDK5 plays a critical role in neuronal cell death pathways.
- Targeting CDK5 may offer novel therapeutic avenues for neurodegenerative diseases.
- Further research into CDK5 partners could elucidate mechanisms and refine treatments.